“Lenzilumab will be evaluated in combination wit
Post# of 148172
(Total Views: 900)
Posted On: 07/27/2020 5:35:12 PM
“Lenzilumab will be evaluated in combination with remdesivir and compared to placebo and remdesivir.”
Way back in April or March, NP mentioned a few times that CYDY has been approved about a potential trial studying the combination of an anti-viral and leronlimab. I don’t remember his exact response, but in typical NP fashion, I believe he said leronlimab didn’t need to be combined with an anti-viral or order to show efficacy.
Was NP talking about this NIH study or remdesevir? I can’t be for sure, but I do believe that NP turned down an opportunity to combine leronlimab with an antiviral in a trial. Does leronlimab need to be combined with another drug? Scientifically, no, but from a business standpoint, hell yes.
Way back in April or March, NP mentioned a few times that CYDY has been approved about a potential trial studying the combination of an anti-viral and leronlimab. I don’t remember his exact response, but in typical NP fashion, I believe he said leronlimab didn’t need to be combined with an anti-viral or order to show efficacy.
Was NP talking about this NIH study or remdesevir? I can’t be for sure, but I do believe that NP turned down an opportunity to combine leronlimab with an antiviral in a trial. Does leronlimab need to be combined with another drug? Scientifically, no, but from a business standpoint, hell yes.
(0)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼